Xspray Pharma AB (publ) (LON:0GHZ)

Xspray Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	125.73	208.24	166.3	120.17	271.88	325.6
Cash & Short-Term Investments	125.73	208.24	166.3	120.17	271.88	325.6
Cash Growth	20.71%	25.21%	38.39%	-55.80%	-16.50%	55.14%
Other Receivables	3.76	4.02	4.17	2.59	2.5	3.32
Receivables	3.76	4.02	4.17	2.59	2.5	3.32
Inventory	30.01	20.34	43.78	8.55	6.2	-
Prepaid Expenses	3.24	2.48	3.57	0.93	1.48	2.1
Other Current Assets	-0	0	-	-0	-0	-
Total Current Assets	162.72	235.07	217.82	132.23	282.07	331.02
Property, Plant & Equipment	77.12	79.18	107.65	64.6	44.6	42.67
Long-Term Investments	0	0	0	0	0	0
Long-Term Deferred Charges	494.67	478.93	436.78	385.6	296.24	231.62
Other Long-Term Assets	3.2	3.17	3.02	3	-	-
Total Assets	737.71	796.34	765.26	585.43	622.9	605.3
Accounts Payable	7.46	17.08	12.47	14.79	16.87	8.44
Accrued Expenses	12.78	18.63	16.31	11.41	10.3	8.54
Short-Term Debt	96	96	-	-	-	-
Current Portion of Leases	5.18	5.11	4.86	1.57	2.05	1.99
Other Current Liabilities	10.05	9.31	6.26	1.09	0.75	0.86
Total Current Liabilities	131.47	146.14	39.9	28.85	29.97	19.82
Long-Term Leases	25.78	27.11	31.95	0.56	1.19	2.9
Other Long-Term Liabilities	0	-0	-	-	-	-
Total Liabilities	157.25	173.25	71.85	29.41	31.15	22.72
Common Stock	37.14	37.14	31.25	22.68	20.68	18.89
Additional Paid-In Capital	1,425	1,425	1,216	907.42	813.48	709.41
Retained Earnings	-881.76	-840.25	-554.72	-374.08	-242.41	-145.71
Comprehensive Income & Other	-	1	0.79	-	-	-
Shareholders' Equity	580.46	623.1	693.41	556.02	591.75	582.59
Total Liabilities & Equity	737.71	796.34	765.26	585.43	622.9	605.3
Total Debt	126.96	128.22	36.81	2.13	3.23	4.88
Net Cash (Debt)	-1.23	80.02	129.5	118.04	268.65	320.72
Net Cash Growth	-	-38.21%	9.70%	-56.06%	-16.23%	56.80%
Net Cash Per Share	-0.04	2.41	4.87	5.60	13.96	18.63
Filing Date Shares Outstanding	37.14	37.14	31.25	22.68	20.68	18.89
Total Common Shares Outstanding	37.14	37.14	31.25	22.68	20.68	18.89
Working Capital	31.26	88.93	177.91	103.38	252.1	311.2
Book Value Per Share	15.63	16.78	22.19	24.52	28.61	30.84
Tangible Book Value	580.46	623.1	693.41	556.02	591.75	582.59
Tangible Book Value Per Share	15.63	16.78	22.19	24.52	28.61	30.84
Machinery	-	51.5	52.12	49.82	46.96	39.87
Construction In Progress	-	41.39	59.37	46.57	20.04	15.75

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.